AI in life sciences raises various patent law considerations, including subject matter eligibility, novelty/obviousness, and ...

A looming patent cliff is driving Big Pharma reorganization. Executives making career moves must understand differences in ...

Rick Modi’s background in pharmacy gave him the scientific and analytical chops to pursue an MBA and ultimately lead innovative gene therapy companies.

Sitryx CEO Iain Kilty describes the biopharmaceutical industry effort to go beyond immunosuppression in autoimmune and ...

IMMvention Therapeutix, Inc., an innovative biotechnology company based in Durham, has announced a strategic collaboration with Novo Nordisk A/S. This partnership aims to co-develop oral therapies for ...

The trial master file (TMF) has become a growing priority for pharmaceutical companies and regulators alike. Effective TMF management ensures compliance and inspection readiness, making the role of ...

A startup based in Research Triangle Park is making significant strides in transforming the tedious and time-consuming process of sample preparation, which is crucial in laboratory settings. Redbud ...

The pharmaceutical industry faces escalating expenditures due to the complexity of traditional clinical trials, fragile supply chains, and increasing regulatory pressures, prompting a shift toward ...

Sponsored genetic testing programs can run afoul of federal laws, including the FCA and AKS, if not designed correctly. Experts at Morrison Foerster share best practices for compliance.